As of 3:57pm ET
| +0.005 / +0.29%|
The 2 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 4.25, with a high estimate of 4.50 and a low estimate of 4.00. The median estimate represents a +143.55% increase from the last price of 1.75.
The current consensus among 3 polled investment analysts is to Hold stock in Accretive Health Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.